Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

IMV

(IMV)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:TSXV:IMV

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
26/08/2014	20h25	PR Newswire (Canada)	IIROC Trading Resumption - IMV	TSXV:IMV
26/08/2014	20h25	PR Newswire (Canada)	L’OCRCVM permet la reprise de la négociation - IMV	TSXV:IMV
26/08/2014	14h16	PR Newswire (Canada)	IIROC Trading Halt - IMV	TSXV:IMV
26/08/2014	14h16	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - IMV	TSXV:IMV
11/06/2014	15h18	Marketwired Canada	Immunovaccine Appoints Marc Mansour as Chief Executive Officer	TSXV:IMV
02/06/2014	14h05	Marketwired	Immunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014	TSXV:IMV
28/05/2014	23h05	Marketwired	Immunovaccine Announces Financial Results for Quarter Ended March 31, 2014	TSXV:IMV
20/05/2014	14h05	Marketwired	Immunovaccine's Novel Immunotherapy Triggers Partial Response & Generates Potent Immune Responses in Ovarian Cancer Clinical ...	TSXV:IMV
12/05/2014	23h31	Marketwired Canada	Immunovaccine Clarifies May 12, 2014 Trading Activity	TSXV:IMV
07/05/2014	16h42	Marketwired Canada	Immunovaccine Announces Withdrawal of Preliminary Prospectus	TSXV:IMV
06/05/2014	21h16	Marketwired Canada	Immunovaccine Announces Overnight Marketed Equity Financing	TSXV:IMV
24/04/2014	14h05	Marketwired	Immunovaccine Announces Results of 2014 Annual General Meeting	TSXV:IMV
08/04/2014	14h05	Marketwired	Immunovaccine's DepoVax(TM) Technology Underpins New Experimental Therapy for Cervical, Head and Neck Cancers	TSXV:IMV
07/04/2014	14h05	Marketwired Canada	Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AAC...	TSXV:IMV
03/04/2014	14h05	Marketwired	Immunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual Meeting	TSXV:IMV
01/04/2014	14h05	Marketwired	Immunovaccine and Pfenex Report Positive Results from Single Dose Anthrax Vaccine Studies	TSXV:IMV
17/03/2014	13h05	Marketwired Canada	Immunovaccine Announces 2013 Year-End Results	TSXV:IMV
20/01/2014	14h07	Marketwired	Llew Keltner, US Biotech Industry Adviser, Joins Board of Immunovaccine	TSXV:IMV
20/01/2014	14h05	Marketwired	Immunovaccine Grants Stock Options	TSXV:IMV
09/01/2014	14h05	Marketwired	Immunovaccine to Present at 6th Annual Biotech Showcase Conference	TSXV:IMV
16/12/2013	14h05	Marketwired	Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors	TSXV:IMV
29/11/2013	14h05	Marketwired	Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013	TSXV:IMV
21/11/2013	13h05	Marketwired Canada	Immunovaccine Raises $4.2 Million in Private Placement	TSXV:IMV
28/10/2013	13h05	Marketwired Canada	Immunovaccine Announces a Non-Brokered Private Placement of $3.2 million	TSXV:IMV
11/10/2013	22h54	Marketwired Canada	Immunovaccine Retains B & D Capital Partners For Strategic Investor Relations Services	TSXV:IMV
09/09/2013	14h17	Marketwired Canada	Immunovaccine Reports Positive Results from Two Anthrax Studies	TSXV:IMV
03/09/2013	22h05	Marketwired Canada	Immunovaccine Announces Management Team Changes	TSXV:IMV
29/08/2013	23h05	Marketwired Canada	Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2013	TSXV:IMV
02/08/2013	15h27	Marketwired Canada	Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) Platform	TSXV:IMV
15/07/2013	14h05	Marketwired Canada	Immunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac	TSXV:IMV

Showing the most relevant articles for your search:TSXV:IMV

1 2 3 4 5 Suivant >>

Cie de SaintGobain

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales